Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Operating Expenses: 2009-2025

Historic Operating Expenses for China Pharma Holdings (CPHI) over the last 17 years, with Sep 2025 value amounting to $568,491.

  • China Pharma Holdings' Operating Expenses rose 0.51% to $568,491 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 4.43%. This contributed to the annual value of $2.6 million for FY2024, which is 5.36% up from last year.
  • Per China Pharma Holdings' latest filing, its Operating Expenses stood at $568,491 for Q3 2025, which was up 0.60% from $565,110 recorded in Q2 2025.
  • China Pharma Holdings' 5-year Operating Expenses high stood at $1.2 million for Q4 2022, and its period low was $309,647 during Q2 2023.
  • For the 3-year period, China Pharma Holdings' Operating Expenses averaged around $620,919, with its median value being $568,491 (2025).
  • Its Operating Expenses has fluctuated over the past 5 years, first tumbled by 53.38% in 2021, then spiked by 50.24% in 2025.
  • China Pharma Holdings' Operating Expenses (Quarterly) stood at $950,626 in 2021, then rose by 27.46% to $1.2 million in 2022, then fell by 8.78% to $1.1 million in 2023, then dropped by 6.32% to $1.0 million in 2024, then rose by 0.51% to $568,491 in 2025.
  • Its last three reported values are $568,491 in Q3 2025, $565,110 for Q2 2025, and $622,557 during Q1 2025.